Evidence map›Paper›PMID 35392263›Full record

ArticleDose-response : a publication of International Hormesis Society

Revisiting the Paradox of Smoking: Radioactivity in Tobacco Smoke or Suppressing the SARS-CoV-2 Receptor, Angiotensin-Converting Enzyme 2, via Aryl-Hydrocarbon Receptor Signal?

Seyed Alireza Mortazavi, Joseph J Bevelacqua, Payman Rafiepour, AbdolKarim Ghadimi-Moghadam, Pooya Saraie, Najmeh Jooyan, Seyedeh Hanieh Mortazavi, Seyed Mohammad Javad Mortazavi, James S Welsh

Open access · goldAbstract read
In one paragraph

Article in Dose-response : a publication of International Hormesis Society. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 60% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Seyed Alireza MortazaviSchool of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Joseph J BevelacquaBevelacqua Resources, Richland, WA, USA.
Payman RafiepourDepartment of Nuclear Engineering, School of Mechanical Engineering, Shiraz University, Shiraz, Iran.
AbdolKarim Ghadimi-MoghadamPediatric Infection Control Dept, School of Medicine, Yasuj University of Medical Sciences, Yasuj, Iran.
Pooya SaraieRadiology Department, School of Paramedical Sciences, Shiraz University of Medical Sciences, Shiraz, Iran.ORCID https://orcid.org/0000-0002-5465-8313
Najmeh JooyanMedical Physics and Engineering Department, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Seyedeh Hanieh MortazaviSchool of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Seyed Mohammad Javad MortazaviMedical Physics and Engineering Department, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.ORCID https://orcid.org/0000-0003-0139-2774
James S WelshDepartment of Radiation Oncology Edward Hines Jr VA Hospital Hines, IL, USA.
Shiraz University of Medical Sciences · IRLoyola University Chicago · USShiraz University · IRYasuj University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite current controversies, some reports show a paradoxical mitigating effect associated with smoking in individuals with symptomatic COVID-19 compared to the general population. To explain the potential mechanisms behind the lower number of hospitalized COVID-19 patients, it has been hypothesized that cigarette smoking may reduce the odds of cytokine storm and related severe inflammatory responses through cholinergic-mediated anti-inflammatory mechanisms. Japanese scientists have recently identified a potential mechanism behind the lower numbers of COVID-19 cases amongst smokers compared to non-smokers. However, we believe that this mitigative effect may be due to the relatively high concentration of deposited energy of alpha particles emitted from naturally occurring radionuclides such as Po-210 in cigarette tobacco. Regarding COVID-19, other researchers and our team have previously addressed the anti-inflammatory and immune-modulating effects of low doses of ionizing radiation. MC-simulation using the Geant4 Monte Carlo toolkit shows that the radiation dose absorbed in a spherical cell with a radius of .9 μm for a single 5.5 MeV alpha particle is about 5.1 Gy. This energy deposition may trigger both anti-inflammatory and anti-thrombotic effects which paradoxically lower the risk of hospitalization due to COVID-19 in smokers.

Indexed as

COVID-19hospitalizationradioactivityseveritysmokingtobacco

Identifiers

PMID35392263
PMCPMC8980405
OpenAlexW4223473427

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.